These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 34585634)

  • 1. MicroRNA-195-3p inhibits cyclin dependent kinase 1 to induce radiosensitivity in nasopharyngeal carcinoma.
    Xie F; Xiao W; Tian Y; Lan Y; Zhang C; Bai L
    Bioengineered; 2021 Dec; 12(1):7325-7334. PubMed ID: 34585634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA PTPRG-AS1/microRNA-124-3p regulates radiosensitivity of nasopharyngeal carcinoma via the LIM Homeobox 2-dependent Notch pathway through competitive endogenous RNA mechanism.
    Shen Z; Wu Y; He G
    Bioengineered; 2022 Apr; 13(4):8208-8225. PubMed ID: 35300558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-19b-3p regulates nasopharyngeal carcinoma radiosensitivity by targeting TNFAIP3/NF-κB axis.
    Huang T; Yin L; Wu J; Gu JJ; Wu JZ; Chen D; Yu HL; Ding K; Zhang N; Du MY; Qian LX; Lu ZW; He X
    J Exp Clin Cancer Res; 2016 Dec; 35(1):188. PubMed ID: 27919278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved Radiotherapy Sensitivity of Nasopharyngeal Carcinoma Cells by miR-29-3p Targeting COL1A1 3'-UTR.
    Guo Y; Zhai J; Zhang J; Ni C; Zhou H
    Med Sci Monit; 2019 Apr; 25():3161-3169. PubMed ID: 31034464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EIF4A3-induced circFIP1L1 represses miR-1253 and promotes radiosensitivity of nasopharyngeal carcinoma.
    Zhou X; Yuan G; Wu Y; Yan S; Jiang Q; Tang S
    Cell Mol Life Sci; 2022 Jun; 79(7):357. PubMed ID: 35680727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of EB virus miR-BART4 inhibits proliferation and aggressiveness while promoting radiosensitivity of nasopharyngeal carcinoma.
    Wu Q; Han T; Sheng X; Zhang N; Wang P
    Biomed Pharmacother; 2018 Dec; 108():741-751. PubMed ID: 30248542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-128-3p increases the radiosensitivity in nasopharyngeal carcinoma via regulating vascular endothelial growth factor C.
    Peng L; Wang Y; Luo J; Liu Y; Wang F
    Pathol Res Pract; 2023 Sep; 249():154768. PubMed ID: 37639953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [circ-WHSC1 affects the growth, metastasis and radiotherapy sensitivity of nasopharyngeal carcinoma cells by targeting miR-338-3p/ELAVL1 axis].
    Li Y; Li YJ; Yu M; Zhao D; Ding ZL
    Zhonghua Zhong Liu Za Zhi; 2022 Nov; 44(11):1175-1185. PubMed ID: 36380666
    [No Abstract]   [Full Text] [Related]  

  • 9. MiR-185-3p and miR-324-3p Predict Radiosensitivity of Nasopharyngeal Carcinoma and Modulate Cancer Cell Growth and Apoptosis by Targeting SMAD7.
    Xu J; Ai Q; Cao H; Liu Q
    Med Sci Monit; 2015 Sep; 21():2828-36. PubMed ID: 26390174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-124-3p inhibits the growth and metastasis of nasopharyngeal carcinoma cells by targeting STAT3.
    Xu S; Zhao N; Hui L; Song M; Miao ZW; Jiang XJ
    Oncol Rep; 2016 Mar; 35(3):1385-94. PubMed ID: 26707908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. microRNA-124 inhibits stem-like properties and enhances radiosensitivity in nasopharyngeal carcinoma cells via direct repression of expression of JAMA.
    Tian Y; Tian Y; Tu Y; Zhang G; Zeng X; Lin J; Ai M; Mao Z; Zheng R; Yuan Y
    J Cell Mol Med; 2020 Sep; 24(17):9533-9544. PubMed ID: 32681617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CircZNF609 promotes cell proliferation, migration, invasion, and glycolysis in nasopharyngeal carcinoma through regulating HRAS via miR-338-3p.
    Liu Z; Liu F; Wang F; Yang X; Guo W
    Mol Cell Biochem; 2021 Jan; 476(1):175-186. PubMed ID: 32970285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA PTPRG-AS1 acts as a microRNA-194-3p sponge to regulate radiosensitivity and metastasis of nasopharyngeal carcinoma cells via PRC1.
    Yi L; Ouyang L; Wang S; Li SS; Yang XM
    J Cell Physiol; 2019 Aug; 234(10):19088-19102. PubMed ID: 30993702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-372 enhances radiosensitivity while inhibiting cell invasion and metastasis in nasopharyngeal carcinoma through activating the PBK-dependent p53 signaling pathway.
    Wang Z; Mao JW; Liu GY; Wang FG; Ju ZS; Zhou D; Wang RY
    Cancer Med; 2019 Feb; 8(2):712-728. PubMed ID: 30656832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inhibition of tumor protein p53 by microRNA-151a-3p induced cell proliferation, migration and invasion in nasopharyngeal carcinoma.
    Liu H; Cheng Y; Xu Y; Xu H; Lin Z; Fan J; Lang J
    Biosci Rep; 2019 Oct; 39(10):. PubMed ID: 31652456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hsa-miR-24-3p increases nasopharyngeal carcinoma radiosensitivity by targeting both the 3'UTR and 5'UTR of Jab1/CSN5.
    Wang S; Pan Y; Zhang R; Xu T; Wu W; Zhang R; Wang C; Huang H; Calin CA; Yang H; Claret FX
    Oncogene; 2016 Nov; 35(47):6096-6108. PubMed ID: 27157611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of lncRNA XIST inhibits hypoxia-induced glycolysis, migration and invasion through regulating miR-381-3p/NEK5 axis in nasopharyngeal carcinoma.
    Zhao CH; Bai XF; Hu XH
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2505-2517. PubMed ID: 32196601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Dicer1 targeted by EBV-miR-BART6-5p on biological properties and radiosensitivity of nasopharyngeal carcinoma.
    Tang J; Liu ZY; Tang Y; Wang Y
    Hum Exp Toxicol; 2021 Jun; 40(6):977-993. PubMed ID: 33305599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-378g enhanced radiosensitivity of NPC cells partially by targeting protein tyrosine phosphatase SHP-1.
    Lin T; Zhou F; Zhou H; Pan X; Sun Z; Peng G
    Int J Radiat Biol; 2015; 91(11):859-66. PubMed ID: 26473472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-185-3p regulates nasopharyngeal carcinoma radioresistance by targeting WNT2B in vitro.
    Li G; Wang Y; Liu Y; Su Z; Liu C; Ren S; Deng T; Huang D; Tian Y; Qiu Y
    Cancer Sci; 2014 Dec; 105(12):1560-8. PubMed ID: 25297925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.